Selected research
Market Structure
Global Vitamin B12 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vitamin B12 Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Vitamin B12 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vitamin B12 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vitamin B12 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vitamin B12 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vitamin B12 Injection include Viwit, Tiantaimount Pharmaceutical, CSPC, Shanghaipujinlinzhou Pharmacy, Nanjing King-Friend Biochemical Pharmaceutical, Vitruvias Therapeutics, Somerset Pharma, Sola Pharmaceuticals and Panbiotic Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vitamin B12 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vitamin B12 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vitamin B12 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin B12 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Vitamin B12 Injection Segment by Company
Viwit
Tiantaimount Pharmaceutical
CSPC
Shanghaipujinlinzhou Pharmacy
Nanjing King-Friend Biochemical Pharmaceutical
Vitruvias Therapeutics
Somerset Pharma
Sola Pharmaceuticals
Panbiotic Laboratories
Padagis
Olympia Pharmaceuticals
Meitheal Pharmaceuticals
Medisca
Lifestar Pharma
Hikma Pharmaceuticals USA
EUROAPI
Empower
American Regent
AdvaCare Pharma
Actavis
Accord Healthcare
Vitamin B12 Injection Segment by Type
Cyanocobalamin Injection
Hydroxocobalamin Injection
Vitamin B12 Injection Segment by Application
Malnutrition
Gastric Disease
Diabetes
Pernicious Anemia
Others
Vitamin B12 Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin B12 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin B12 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin B12 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vitamin B12 Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vitamin B12 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vitamin B12 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vitamin B12 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cyanocobalamin Injection
- Hydroxocobalamin Injection
Applications
- Malnutrition
- Gastric Disease
- Diabetes
- Pernicious Anemia
- Others
Companies covered
- Viwit
- Tiantaimount Pharmaceutical
- CSPC
- Shanghaipujinlinzhou Pharmacy
- Nanjing King-Friend Biochemical Pharmaceutical
- Vitruvias Therapeutics
- Somerset Pharma
- Sola Pharmaceuticals
- Panbiotic Laboratories
- Padagis
- Olympia Pharmaceuticals
- Meitheal Pharmaceuticals
- Medisca
- Lifestar Pharma
- Hikma Pharmaceuticals USA
- EUROAPI
- Empower
- American Regent
- AdvaCare Pharma
- Actavis
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vitamin B12 Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vitamin B12 Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vitamin B12 Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vitamin B12 Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vitamin B12 Injection Market Dynamics
- 2.1 Vitamin B12 Injection Industry Trends
- 2.2 Vitamin B12 Injection Industry Drivers
- 2.3 Vitamin B12 Injection Industry Opportunities and Challenges
- 2.4 Vitamin B12 Injection Industry Restraints
3 Vitamin B12 Injection Market by Manufacturers
- 3.1 Global Vitamin B12 Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Vitamin B12 Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Vitamin B12 Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vitamin B12 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vitamin B12 Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vitamin B12 Injection Manufacturers, Product Type & Application
- 3.7 Global Vitamin B12 Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vitamin B12 Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vitamin B12 Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Vitamin B12 Injection Tier 1, Tier 2, and Tier 3
4 Vitamin B12 Injection Market by Type
- 4.1 Vitamin B12 Injection Type Introduction
- 4.1.1 Cyanocobalamin Injection
- 4.1.2 Hydroxocobalamin Injection
- 4.2 Global Vitamin B12 Injection Sales by Type
- 4.2.1 Global Vitamin B12 Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vitamin B12 Injection Sales by Type (2021-2032)
- 4.2.3 Global Vitamin B12 Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Vitamin B12 Injection Revenue by Type
- 4.3.1 Global Vitamin B12 Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vitamin B12 Injection Revenue by Type (2021-2032)
- 4.3.3 Global Vitamin B12 Injection Revenue Market Share by Type (2021-2032)
5 Vitamin B12 Injection Market by Application
- 5.1 Vitamin B12 Injection Application Introduction
- 5.1.1 Malnutrition
- 5.1.2 Gastric Disease
- 5.1.3 Diabetes
- 5.1.4 Pernicious Anemia
- 5.1.5 Others
- 5.2 Global Vitamin B12 Injection Sales by Application
- 5.2.1 Global Vitamin B12 Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamin B12 Injection Sales by Application (2021-2032)
- 5.2.3 Global Vitamin B12 Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Vitamin B12 Injection Revenue by Application
- 5.3.1 Global Vitamin B12 Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vitamin B12 Injection Revenue by Application (2021-2032)
- 5.3.3 Global Vitamin B12 Injection Revenue Market Share by Application (2021-2032)
6 Global Vitamin B12 Injection Sales by Region
- 6.1 Global Vitamin B12 Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vitamin B12 Injection Sales by Region (2021-2032)
- 6.2.1 Global Vitamin B12 Injection Sales by Region (2021-2026)
- 6.2.2 Global Vitamin B12 Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vitamin B12 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vitamin B12 Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vitamin B12 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vitamin B12 Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vitamin B12 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vitamin B12 Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vitamin B12 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vitamin B12 Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vitamin B12 Injection Revenue by Region
- 7.1 Global Vitamin B12 Injection Revenue by Region
- 7.1.1 Global Vitamin B12 Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vitamin B12 Injection Revenue by Region (2021-2026)
- 7.1.3 Global Vitamin B12 Injection Revenue by Region (2027-2032)
- 7.1.4 Global Vitamin B12 Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vitamin B12 Injection Revenue (2021-2032)
- 7.2.2 North America Vitamin B12 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vitamin B12 Injection Revenue (2021-2032)
- 7.3.2 Europe Vitamin B12 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vitamin B12 Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vitamin B12 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vitamin B12 Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vitamin B12 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Viwit
- 8.1.1 Viwit Company Information
- 8.1.2 Viwit Business Overview
- 8.1.3 Viwit Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Viwit Vitamin B12 Injection Product Portfolio
- 8.1.5 Viwit Recent Developments
- 8.2 Tiantaimount Pharmaceutical
- 8.2.1 Tiantaimount Pharmaceutical Company Information
- 8.2.2 Tiantaimount Pharmaceutical Business Overview
- 8.2.3 Tiantaimount Pharmaceutical Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tiantaimount Pharmaceutical Vitamin B12 Injection Product Portfolio
- 8.2.5 Tiantaimount Pharmaceutical Recent Developments
- 8.3 CSPC
- 8.3.1 CSPC Company Information
- 8.3.2 CSPC Business Overview
- 8.3.3 CSPC Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CSPC Vitamin B12 Injection Product Portfolio
- 8.3.5 CSPC Recent Developments
- 8.4 Shanghaipujinlinzhou Pharmacy
- 8.4.1 Shanghaipujinlinzhou Pharmacy Company Information
- 8.4.2 Shanghaipujinlinzhou Pharmacy Business Overview
- 8.4.3 Shanghaipujinlinzhou Pharmacy Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghaipujinlinzhou Pharmacy Vitamin B12 Injection Product Portfolio
- 8.4.5 Shanghaipujinlinzhou Pharmacy Recent Developments
- 8.5 Nanjing King-Friend Biochemical Pharmaceutical
- 8.5.1 Nanjing King-Friend Biochemical Pharmaceutical Company Information
- 8.5.2 Nanjing King-Friend Biochemical Pharmaceutical Business Overview
- 8.5.3 Nanjing King-Friend Biochemical Pharmaceutical Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Nanjing King-Friend Biochemical Pharmaceutical Vitamin B12 Injection Product Portfolio
- 8.5.5 Nanjing King-Friend Biochemical Pharmaceutical Recent Developments
- 8.6 Vitruvias Therapeutics
- 8.6.1 Vitruvias Therapeutics Company Information
- 8.6.2 Vitruvias Therapeutics Business Overview
- 8.6.3 Vitruvias Therapeutics Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vitruvias Therapeutics Vitamin B12 Injection Product Portfolio
- 8.6.5 Vitruvias Therapeutics Recent Developments
- 8.7 Somerset Pharma
- 8.7.1 Somerset Pharma Company Information
- 8.7.2 Somerset Pharma Business Overview
- 8.7.3 Somerset Pharma Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Somerset Pharma Vitamin B12 Injection Product Portfolio
- 8.7.5 Somerset Pharma Recent Developments
- 8.8 Sola Pharmaceuticals
- 8.8.1 Sola Pharmaceuticals Company Information
- 8.8.2 Sola Pharmaceuticals Business Overview
- 8.8.3 Sola Pharmaceuticals Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sola Pharmaceuticals Vitamin B12 Injection Product Portfolio
- 8.8.5 Sola Pharmaceuticals Recent Developments
- 8.9 Panbiotic Laboratories
- 8.9.1 Panbiotic Laboratories Company Information
- 8.9.2 Panbiotic Laboratories Business Overview
- 8.9.3 Panbiotic Laboratories Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Panbiotic Laboratories Vitamin B12 Injection Product Portfolio
- 8.9.5 Panbiotic Laboratories Recent Developments
- 8.10 Padagis
- 8.10.1 Padagis Company Information
- 8.10.2 Padagis Business Overview
- 8.10.3 Padagis Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Padagis Vitamin B12 Injection Product Portfolio
- 8.10.5 Padagis Recent Developments
- 8.11 Olympia Pharmaceuticals
- 8.11.1 Olympia Pharmaceuticals Company Information
- 8.11.2 Olympia Pharmaceuticals Business Overview
- 8.11.3 Olympia Pharmaceuticals Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Olympia Pharmaceuticals Vitamin B12 Injection Product Portfolio
- 8.11.5 Olympia Pharmaceuticals Recent Developments
- 8.12 Meitheal Pharmaceuticals
- 8.12.1 Meitheal Pharmaceuticals Company Information
- 8.12.2 Meitheal Pharmaceuticals Business Overview
- 8.12.3 Meitheal Pharmaceuticals Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Meitheal Pharmaceuticals Vitamin B12 Injection Product Portfolio
- 8.12.5 Meitheal Pharmaceuticals Recent Developments
- 8.13 Medisca
- 8.13.1 Medisca Company Information
- 8.13.2 Medisca Business Overview
- 8.13.3 Medisca Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Medisca Vitamin B12 Injection Product Portfolio
- 8.13.5 Medisca Recent Developments
- 8.14 Lifestar Pharma
- 8.14.1 Lifestar Pharma Company Information
- 8.14.2 Lifestar Pharma Business Overview
- 8.14.3 Lifestar Pharma Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Lifestar Pharma Vitamin B12 Injection Product Portfolio
- 8.14.5 Lifestar Pharma Recent Developments
- 8.15 Hikma Pharmaceuticals USA
- 8.15.1 Hikma Pharmaceuticals USA Company Information
- 8.15.2 Hikma Pharmaceuticals USA Business Overview
- 8.15.3 Hikma Pharmaceuticals USA Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Hikma Pharmaceuticals USA Vitamin B12 Injection Product Portfolio
- 8.15.5 Hikma Pharmaceuticals USA Recent Developments
- 8.16 EUROAPI
- 8.16.1 EUROAPI Company Information
- 8.16.2 EUROAPI Business Overview
- 8.16.3 EUROAPI Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 EUROAPI Vitamin B12 Injection Product Portfolio
- 8.16.5 EUROAPI Recent Developments
- 8.17 Empower
- 8.17.1 Empower Company Information
- 8.17.2 Empower Business Overview
- 8.17.3 Empower Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Empower Vitamin B12 Injection Product Portfolio
- 8.17.5 Empower Recent Developments
- 8.18 American Regent
- 8.18.1 American Regent Company Information
- 8.18.2 American Regent Business Overview
- 8.18.3 American Regent Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 American Regent Vitamin B12 Injection Product Portfolio
- 8.18.5 American Regent Recent Developments
- 8.19 AdvaCare Pharma
- 8.19.1 AdvaCare Pharma Company Information
- 8.19.2 AdvaCare Pharma Business Overview
- 8.19.3 AdvaCare Pharma Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 AdvaCare Pharma Vitamin B12 Injection Product Portfolio
- 8.19.5 AdvaCare Pharma Recent Developments
- 8.20 Actavis
- 8.20.1 Actavis Company Information
- 8.20.2 Actavis Business Overview
- 8.20.3 Actavis Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Actavis Vitamin B12 Injection Product Portfolio
- 8.20.5 Actavis Recent Developments
- 8.21 Accord Healthcare
- 8.21.1 Accord Healthcare Company Information
- 8.21.2 Accord Healthcare Business Overview
- 8.21.3 Accord Healthcare Vitamin B12 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Accord Healthcare Vitamin B12 Injection Product Portfolio
- 8.21.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vitamin B12 Injection Value Chain Analysis
- 9.1.1 Vitamin B12 Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vitamin B12 Injection Production Mode & Process
- 9.2 Vitamin B12 Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vitamin B12 Injection Distributors
- 9.2.3 Vitamin B12 Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst